535711000001100: Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \UK product\Virtual medicinal product\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \UK product\Virtual therapeutic moiety\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \UK product\Virtual therapeutic moiety\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \UK product\Trade family\Navispare\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing sodium channel blocker (product)\Product containing amiloride\Product containing amiloride in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing sodium channel blocker (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing sodium channel blocker (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing sodium channel blocker (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing pyrazine (product)\Product containing amiloride\Product containing amiloride in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing pyrazine (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing pyrazine (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing pyrazine (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing cyclopenthiazide\Product containing cyclopenthiazide in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing cyclopenthiazide in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product acting as potassium-sparing diuretic (product)\Product containing amiloride\Product containing amiloride in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product acting as potassium-sparing diuretic (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product acting as potassium-sparing diuretic (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product acting as potassium-sparing diuretic (product)\Product containing amiloride\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing cyclopenthiazide in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Amiloride + Cyclopenthiazide\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing cyclopenthiazide\Product containing amiloride and cyclopenthiazide\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing cyclopenthiazide in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing amiloride in oral dose form (medicinal product form)\Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form)\Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet\Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
16082501000001113	Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
111532801000001112	Navispare 2.5mg/250microgram tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start